A case report describing the use of systemic bevacizumab in the treatment of recurrent respiratory papillomatosis with pulmonary involvement

Respirol Case Rep. 2023 Nov 22;11(12):e01246. doi: 10.1002/rcr2.1246. eCollection 2023 Dec.

Abstract

Recurrent respiratory papillomatosis (RRP) is a rare disease characterized by recurrent papilloma along the aerodigestive tract. In this case, we describe a 16-year-old with longstanding laryngeal RRP secondary to vertical transmission of human papillomavirus (HPV) who presented with symptomatic pulmonary involvement and was successfully treated with systemic bevacizumab. The case describes the clinical and radiological improvement with therapy as well as the adverse effects that occurred and resolved with dose adjustments.

Keywords: avastin; bevacizumab; human viruses; papilloma; recurrent respiratory papillomatosis.

Publication types

  • Case Reports